about
Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathwaysBurden and nutritional deficiencies in opiate addiction- systematic review articleTreating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic reviewActivation of reward circuitry in human opiate addictsDisruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawalRole of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc)Mesoaccumbens dopamine signaling alteration underlies behavioral transition from tolerance to sensitization to morphine rewarding properties during morphine withdrawalDrug abuse: hedonic homeostatic dysregulationCraving for alcohol and drugs in animals and humans: biology and behavior.The role of dopamine in reward and pleasure behaviour--review of data from preclinical research.Translational studies of alcoholism: bridging the gap.Hedonic Homeostatic Dysregulation as a Driver of Drug-Seeking BehaviorDrugs of abuse and the brain.Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens.Ethanol blocks long-term potentiation of GABAergic synapses in the ventral tegmental area involving mu-opioid receptors.How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.The mood cycle hypothesis: possible involvement of steroid hormones in mood regulation by means of Na+, K+-ATPase inhibition.Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment.The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence.Temporal profiles dissociate regional extracellular ethanol versus dopamine concentrations.The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.Pharmacological treatment of cannabis dependence.Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors.Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation.Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2STEP signaling pathway mediates psychomotor stimulation and morphine withdrawal symptoms, but not for reward, analgesia and toleranceThe motivational component of withdrawal in opiate addiction: role of associative learning and aversive memory in opiate addiction from a behavioral, anatomical and functional perspective.Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention.Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors.Reversal effect of intra-central amygdala microinjection of L-arginine on place aversion induced by naloxone in morphine conditioned ratsInsulin receptor substrate-2 in the ventral tegmental area regulates behavioral responses to cocaine.Neurobiological substrates for the dark side of compulsivity in addiction.Pharmacogenetic treatments for drug addiction: alcohol and opiates.Cellular events in nicotine addiction.Morphine dependence is attenuated by red ginseng extract and ginsenosides Rh2, Rg3, and compound K.Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.Agonist-selective endocytosis of mu opioid receptor by neurons in vivo.BOLD Imaging in Awake Wild-Type and Mu-Opioid Receptor Knock-Out Mice Reveals On-Target Activation Maps in Response to Oxycodone.Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelin.
P2860
Q24646270-36118969-4AFA-4CD3-B034-7696156CC409Q26824011-AC82DC5B-059D-4ADE-A6B0-74A7745A1AB0Q26851897-7456AB2E-EBE4-4C4B-8A82-D4CC039D8B09Q28083156-6B2E1BB1-8D4D-45BC-A836-33BD1E5E7DDDQ28140274-5D24EDB5-F776-4299-A969-F93E67DD7AE9Q28379331-A1AC1D6D-7BF8-45B3-988E-E74FDCF98332Q28484325-923708CC-69BF-4F48-A4A4-96F5B832FBE0Q28580986-270DB97E-FB1D-4889-BE77-41F6657CB54FQ29615904-8C0549FB-2277-421D-9A21-6CE9AC117EACQ30664549-84C924A0-334F-4CF4-9686-F5A63E1EC4D0Q33214750-73B3153B-21A9-4238-999A-B85400A83121Q33559892-60EC1471-76DE-4EA9-94BA-795B5D5ED322Q33572392-E592707C-4F33-4882-A119-CD4CFFEBA074Q33603922-776B3368-A34C-4642-88E9-D6C024360003Q33667218-7B78BA9C-090B-4095-800C-FC3F6235B91FQ33998572-078DCDC4-4E47-41AF-AA46-A109AAF2AFF8Q34073903-61452072-34A7-4757-A03A-4F9892998474Q34181229-AD08FF83-176E-4C59-A44B-945B1137BF9AQ34311105-C84346B5-0CFF-4D27-9D7F-2ABBD8B7E469Q34612112-1C48D84E-5900-46C5-86C2-5D77C4DEE029Q35006063-6AF78A3B-6474-4FA0-8415-D541E3F8D5CCQ35184664-C8AEF90D-A42F-4549-A636-EB2ED07F0D46Q35210350-ED63BCBC-6B01-401B-92A8-442E0FD1D654Q35726449-9D7E61CC-03B2-44AA-917B-A60E7D54EF1FQ35748337-733C247D-6999-44D8-B4D7-9856BC24533FQ35756113-EE831BDB-C2D5-4153-B5EE-9E9326400C89Q35936082-8823F144-2FA0-43C0-B583-0B3B6DDBECD5Q36329182-3CB6432D-ADAD-4EB7-8EE8-633C3F85DA7DQ36629372-27731BCD-79E2-4470-99B5-650C2FD01FE4Q36713890-1C132712-ABC0-4174-B3F7-AA62DE66B71DQ36805098-D858ED82-AE75-42A9-84CF-C9F85AB1E3E3Q36925558-FB535179-0AD8-462E-A6EC-F38EEAE40506Q37088658-1496EB4B-7181-4197-8D78-EA36CB87F7F2Q37201611-DFA2FAFF-65CE-411E-8C1C-E0BF8B011229Q37247103-A9B04A63-6259-432F-9B5B-F9DFA3D9160DQ37314448-B43DB82B-71E3-4E2D-9285-9EEE3309EC96Q37356740-1A052387-077B-441B-A56A-901DD928C09FQ37390918-02665892-1F59-4D3F-A2ED-E2635A3B5A5DQ37391107-6A532F48-96B6-4009-83BC-50C920F7135DQ37807998-1311CC54-F0C6-4205-B1EC-08D10B57677A
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Neurobiology of opiate abuse.
@ast
Neurobiology of opiate abuse.
@en
type
label
Neurobiology of opiate abuse.
@ast
Neurobiology of opiate abuse.
@en
prefLabel
Neurobiology of opiate abuse.
@ast
Neurobiology of opiate abuse.
@en
P1476
Neurobiology of opiate abuse.
@en
P2093
P304
P356
10.1016/0165-6147(92)90062-B
P577
1992-05-01T00:00:00Z